Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
JAGSNPHARM | NSE
-4.25
-1.04%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
18/09/2024
405.85
410.75
412.25
405.00
Jagsonpal Pharmaceuticals Limited develops and manufactures bulk drugs and pharmaceutical formulations in the areas of women health pain and analgesics and general medicine. It offers general medicines such as allergy management immunity and cell protection gut and mind management anti-infectives and dentist and ENT range products; and women's healthcare products including pregnancy care and dysfunctional uterine bleeding complications and management products. The company also provides pain and analgesics products in the areas of pain management and bone and joint care. It offers drugs in the form of tablets capsules and syrups. The company was founded in 1964 and is headquartered in New Delhi India. Jagsonpal Pharmaceuticals Limited is a subsidiary of Aresko Progressive Private Limited.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Price Below SMA10D
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
35.4%1 month
43.8%3 months
48.3%6 months
49.9%53.99
-
5.70
0.05
0.04
28.71
4.44
-
241.98M
10.74B
128.41M
1.24
14.92
-32.30
2.10
12.97
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
51.75
Range1M
99.20
Range3M
125.65
Rel. volume
0.25
Price X volume
12.10M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Nectar Lifesciences Limited | NECLIFE | Drug Manufacturers-Specialty & Generic | 46.62 | 10.75B | -2.59% | 201.62 | 59.44% |
Bajaj HealthCare Limited | BAJAJHCARE | Drug Manufacturers-Specialty & Generic | 383.15 | 10.70B | -4.01% | n/a | 119.57% |
Albert David Ltd | ALBERTDAVD | Drug Manufacturers-Specialty & Generic | 1479.35 | 8.44B | -0.14% | 10.74 | 0.87% |
Wanbury Limited | WANBURY | Drug Manufacturers-Specialty & Generic | 253.35 | 8.30B | -1.11% | 16.51 | 416.89% |
Ind-Swift Laboratories Limited | INDSWFTLAB | Drug Manufacturers-Specialty & Generic | 137.79 | 8.14B | -1.82% | 2.10 | 1.78% |
Kilitch Drugs (India) Limited | KILITCH | Drug Manufacturers-Specialty & Generic | 370.4 | 5.99B | -1.71% | 50.24 | 17.95% |
Medicamen Biotech Limited | MEDICAMEQ | Drug Manufacturers-Specialty & Generic | 463.15 | 5.84B | -2.80% | 72.99 | 15.37% |
Zim Laboratories Limited | ZIMLAB | Drug Manufacturers-Specialty & Generic | 112.64 | 5.52B | -0.58% | 31.56 | 45.58% |
Venus Remedies Limited | VENUSREM | Drug Manufacturers-Specialty & Generic | 347.15 | 4.67B | -1.00% | 17.16 | 8.48% |
Brooks Laboratories Limited | BROOKS | Drug Manufacturers-Specialty & Generic | 156.7 | 4.11B | 0.00% | n/a | 8.60% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Bhagyanagar India Ltd | BHAGYANGR | Copper | 106.49 | 3.41B | -2.42% | 34.15 | 52.08% |
Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 172.05 | 1.91B | 1.72% | 49.20 | 4.88% |
Cubex Tubings Limited | CUBEXTUB | Copper | 96.65 | 1.38B | -1.91% | 34.07 | 21.78% |
Madhav Copper Limited | MCL | Copper | 36.91 | 1.03B | -1.89% | n/a | 32.70% |
Heads UP Ventures Limited | HEADSUP | Apparel Retail | 14.89 | 336.84M | -5.34% | n/a | 0.00% |
Suumaya Industries Limited | SUULD | Apparel Retail | 5.05 | 303.87M | -0.98% | n/a | -118.72% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 28.71 | - | Expensive |
Ent. to Revenue | 4.44 | - | Cheaper |
PE Ratio | 53.99 | 47.84 | Par |
Price to Book | 5.70 | 6.55 | Par |
Dividend Yield | 1.24 | - | Leader |
Std. Deviation (3M) | 48.33 | - | Par |
Debt to Equity | 0.05 | 0.34 | Cheaper |
Debt to Assets | 0.04 | 0.17 | Cheaper |
Market Cap | 10.74B | - | Emerging |